Biological and computational evaluation of resveratrol inhibitors against Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Enzyme Inhibition and Medicinal Chemistry

• Publication date

  2016-01-02

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3109/14756366.2014.1003928PMID 26147348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mixed ligand Cu2+ complexes of a model therapeutic with Alzheimer's amyloid-β peptide and monoamine neurotransmitters.

  2013cited by this paper
• Enhanced Phosphatidylinositol 3-kinase (PI3K)/Akt Signaling Has Pleiotropic Targets in Hippocampal Neurons Exposed to Iron-induced Oxidative Stress*

  2013cited by this paper
• Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.

  2013cited by this paper
• Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells.

  2013cited by this paper
• Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo.

  2013cited by this paper
• Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease.

  2012cited by this paper
• Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.

  2012cited by this paper
• Protonation States of the Catalytic Dyad of β-Secretase (BACE1) in the Presence of Chemically Diverse Inhibitors: A Molecular Docking Study

  2012cited by this paper
• Chemical modification of the multitarget neuroprotective compound fisetin.

  2012cited by this paper
• Developing β‐secretase inhibitors for treatment of Alzheimer’s disease

  2012cited by this paper
• Neuroprotective Effect of Natural Products Against Alzheimer’s Disease

  2012cited by this paper
• Combining Dyad Protonation and Active Site Plasticity in BACE-1 Structure-Based Drug Design

  2012cited by this paper
• Quantum mechanics study of the hydroxyethylamines–BACE-1 active site interaction energies

  2011cited by this paper
• New hydroxystilbenoid derivatives endowed with neuroprotective activity and devoid of interference with estrogen and aryl hydrocarbon receptor-mediated transcription.

  2011cited by this paper
• Comparison of thermal effects of stilbenoid analogs in lipid bilayers using differential scanning calorimetry and molecular dynamics: correlation of thermal effects and topographical position with antioxidant activity

  2011cited by this paper
• Alzheimer's disease & metals: therapeutic opportunities

  2011cited by this paper
• Inhibition and Structural Reliability of Prenylated Flavones from the Stem Bark of Morus lhou on β‐Secretase (BACE‐1).

  2011cited by this paper
• Interplay between acoustic/phonetic and semantic processes during spoken sentence comprehension: an ERP study.

  2011cited by this paper
• Inhibition and structural reliability of prenylated flavones from the stem bark of Morus lhou on β-secretase (BACE-1).

  2011cited by this paper
• PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions.

  2011cited by this paper
• In vitro BACE-1 inhibitory activity of resveratrol oligomers from the seed extract of Paeonia lactiflora.

  2011cited by this paper
• On a possible neutral charge state for the catalytic dyad in β-secretase when bound to hydroxyethylene transition state analogue inhibitors.

  2011cited by this paper
• Tautomer Preference in PDB Complexes and its Impact on Structure-Based Drug Discovery

  2010cited by this paper
• beta-Secretase (BACE-1) inhibitory effect of biflavonoids.

  2010cited by this paper
• New Guaiane Sesquiterpene Lactones from Ixeris dentata

  2010cited by this paper
• Identification of a small molecule beta-secretase inhibitor that binds without catalytic aspartate engagement.

  2009cited by this paper
• Differential estrogen receptor subtype modulators: assessment of estrogen receptor subtype-binding selectivity and transcription-regulating properties of new cycloalkyl pyrazoles.

  2009cited by this paper
• Substrate binding mechanism of HIV-1 protease from explicit-solvent atomistic simulations.

  2009cited by this paper
• A New Specific BACE-1 Inhibitor from the Stembark Extract of Vitis vinifera

  2009cited by this paper
• Predicting drug resistance of the HIV‐1 protease using molecular interaction energy components

  2009cited by this paper
• Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.

  2008cited by this paper
• Very fast prediction and rationalization of pKa values for protein–ligand complexes

  2008cited by this paper
• Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases.

  2008cited by this paper
• Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features.

  2008cited by this paper
• Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation

  2008influential reference
• BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens.

  2008cited by this paper
• Engineered chimeric enzymes as tools for drug discovery: generating reliable bacterial screens for the detection, discovery, and assessment of estrogen receptor modulators.

  2007cited by this paper
• New and Original pKa Prediction Method Using Grid Molecular Interaction Fields

  2007cited by this paper
• β-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma

  2007cited by this paper
• Beta-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma.

  2007cited by this paper
• Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

  2006cited by this paper
• Linear interaction energy models for beta-secretase (BACE) inhibitors: Role of van der Waals, electrostatic, and continuum-solvation terms.

  2006cited by this paper
• Comparison of multiple Amber force fields and development of improved protein backbone parameters

  2006cited by this paper
• The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression.

  2006cited by this paper
• Chroman/catechol hybrids: synthesis and evaluation of their activity against oxidative stress induced cellular damage.

  2006cited by this paper
• Assigning the protonation states of the key aspartates in β-Secretase using QM/MM X-ray structure refinement.

  2006cited by this paper
• β-Secretase(BACE1) inhibitors from pomegranate (Punica granatum) husk

  2005cited by this paper
• Virtual screening for beta-secretase (BACE1) inhibitors reveals the importance of protonation states at Asp32 and Asp228.

  2005cited by this paper
• β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways

  2005cited by this paper
• Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides*

  2005cited by this paper
• Modeling the Protonation States of the Catalytic Aspartates in β-Secretase

  2004cited by this paper
• Development and testing of a general amber force field

  2004cited by this paper
• Apo and inhibitor complex structures of BACE (beta-secretase).

  2004cited by this paper
• Apo and Inhibitor Complex Structures of BACE (β-secretase)

  2004cited by this paper
• Modeling the protonation states of the catalytic aspartates in beta-secretase.

  2004cited by this paper
• Green tea catechins as a BACE1 (beta-secretase) inhibitor.

  2003cited by this paper
• Determination of the active site protonation state of beta-secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design.

  2003cited by this paper
• Protocol for MM/PBSA molecular dynamics simulations of proteins.

  2003cited by this paper
• Green tea catechins as a BACE1 (β-secretase) inhibitor

  2003cited by this paper
• Specificity of resistance to oxidative stress

  2002cited by this paper
• Langevin stabilization of molecular dynamics

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

  2001cited by this paper
• Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions.

  2001cited by this paper
• Predicting blood-brain barrier permeation from three-dimensional molecular structure.

  2000cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models.

  2000cited by this paper
• Molecular fields in quantitative structure–permeation relationships: the VolSurf approach

  2000cited by this paper
• Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)

  1999cited by this paper
• Reduced surface: an efficient way to compute molecular surfaces.

  1996cited by this paper
• Classical electrostatics in biology and chemistry.

  1995cited by this paper
• Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

  1993cited by this paper
• Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 18O isotope exchange.

  1991cited by this paper
• Strategic approaches to drug design. I. An integrated software framework for molecular modelling

  1987cited by this paper
• Comparison of simple potential functions for simulating liquid water

  1983cited by this paper
• Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes

  1977cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper

• Molecular mechanisms underlying the neuroprotective effects of polyphenols: implications for cognitive function

  2025cites this paper
• The Potential of Resveratrol as an Anticancer Agent: Updated Overview of Mechanisms, Applications, and Perspectives

  2025cites this paper
• Phytocompounds as modulators of HSF1 in Neurodegenerative disease: Special emphasis on Alzheimer's disease.

  2025cites this paper
• Stilbenes Against Alzheimer’s Disease: A Comprehensive Review of Preclinical Studies of Natural and Synthetic Compounds Combined with the Contributions of Developed Nanodrug Delivery Systems

  2025cites this paper
• Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11

  2023cites this paper
• Phytochemical Interactions with Calmodulin and Critical Calmodulin Binding Proteins Involved in Amyloidogenesis in Alzheimer’s Disease

  2023cites this paper
• Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes

  2022cites this paper
• Interdisciplinary Approaches to Deal with Alzheimer’s Disease—From Bench to Bedside: What Feasible Options Do Already Exist Today?

  2022cites this paper
• Protective and anti-oxidative effects of curcumin and resveratrol on Aβ-oligomer-induced damage in the SH-SY5Y cell line.

  2022cites this paper
• Identification of potential human beta-secretase 1 inhibitors by hierarchical virtual screening and molecular dynamics

  2022cites this paper
• Study of Resveratrol’s Interaction with Planar Lipid Models: Insights into Its Location in Lipid Bilayers

  2021cites this paper
• Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases

  2021influential citation
• Role of Natural Products for the Treatment of Alzheimer's Disease.

  2021cites this paper
• Natural products: A lead for drug discovery and development

  2021cites this paper
• Structure-based virtual screening for novel potential selective inhibitors of class IIa histone deacetylases for cancer treatment

  2021cites this paper
• Curcumin in Alzheimer’s disease diagnosis and treatment

  2021cites this paper
• Nutraceutical approach to age-related diseases—The clinical evidence on cognitive decline

  2021cites this paper
• Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation

  2021cites this paper
• Ferroptosis Mechanisms Involved in Neurodegenerative Diseases

  2020cites this paper
• Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development

  2020cites this paper
• Effective estimation of the inhibitor affinity of HIV-1 protease via a modified LIE approach

  2020cites this paper
• Resveratrol-mediated cleavage of amyloid β1-42 peptide: potential relevance to Alzheimer's disease.

  2020cites this paper
• Adequate prediction for inhibitor affinity of Aβ40 protofibril using the linear interaction energy method

  2019cites this paper
• Resveratrol and cognitive decline: a clinician perspective

  2019cites this paper
• Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools

  2019cites this paper
• Resveratrol and Its Analogues: Recent Advances in Structural Modification and Bioactivity.

  2019cites this paper
• Recent Developments and Applications of the MMPBSA Method

  2018cites this paper
• Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design

  2018cites this paper
• Understanding the role of resveratrol in major neurological and lifestyle diseases: an insight into molecular mechanisms anddruggability

  2018cites this paper
• β‐Secretase (BACE1) Inhibitors from Natural Products

  2017cites this paper
• Biophenols pharmacology against the amyloidogenic activity in Alzheimer's disease.

  2017cites this paper
• Resveratrol and Amyloid-Beta: Mechanistic Insights

  2017cites this paper
• Resveratrol and Alzheimer’s Disease: Mechanistic Insights

  2017cites this paper
• Botanicals and phytochemicals active on cognitive decline: The clinical evidence

  2017cites this paper
• Synthesis of some tetrahydropyrimidine-5-carboxylates, determination of their metal chelating effects and inhibition profiles against acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase

  2016cites this paper
• Curcumin and Resveratrol in the Management of Cognitive Disorders: What Is the Clinical Evidence?

  2016cites this paper